Study for the Oncology Bolded Information Test. Engage with interactive questions and detailed explanations. Prepare thoroughly for your exam!

Multiple Choice

What percentage of lymphoblasts is typically seen on a bone marrow biopsy of acute lymphoblastic leukemia (ALL)?

In acute lymphoblastic leukemia (ALL), bone marrow biopsy findings typically show a high proportion of lymphoblasts, which are immature lymphocytes. The hallmark of ALL is the presence of a significant percentage of these lymphoblasts, often exceeding 20% of the total bone marrow cellularity. While the specifics can vary from case to case, 20% serves as a commonly recognized threshold indicating a diagnosis of ALL. This is supported by clinical and laboratory data that classify the disease based on the substantial infiltration of the bone marrow with these malignant cells. A higher percentage, such as 30% or 40%, may also be seen in more severe cases or in specific subtypes, but the diagnosis of ALL can start at around 20%. Thus, identifying 20% of lymphoblasts in a bone marrow biopsy is a significant finding that aligns with the diagnostic criteria for acute lymphoblastic leukemia.

In acute lymphoblastic leukemia (ALL), bone marrow biopsy findings typically show a high proportion of lymphoblasts, which are immature lymphocytes. The hallmark of ALL is the presence of a significant percentage of these lymphoblasts, often exceeding 20% of the total bone marrow cellularity.

While the specifics can vary from case to case, 20% serves as a commonly recognized threshold indicating a diagnosis of ALL. This is supported by clinical and laboratory data that classify the disease based on the substantial infiltration of the bone marrow with these malignant cells. A higher percentage, such as 30% or 40%, may also be seen in more severe cases or in specific subtypes, but the diagnosis of ALL can start at around 20%.

Thus, identifying 20% of lymphoblasts in a bone marrow biopsy is a significant finding that aligns with the diagnostic criteria for acute lymphoblastic leukemia.